全文获取类型
收费全文 | 29597篇 |
免费 | 2260篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 264篇 |
儿科学 | 1050篇 |
妇产科学 | 856篇 |
基础医学 | 4028篇 |
口腔科学 | 431篇 |
临床医学 | 3960篇 |
内科学 | 5514篇 |
皮肤病学 | 631篇 |
神经病学 | 2983篇 |
特种医学 | 689篇 |
外国民族医学 | 2篇 |
外科学 | 2754篇 |
综合类 | 261篇 |
一般理论 | 25篇 |
预防医学 | 3808篇 |
眼科学 | 597篇 |
药学 | 1662篇 |
1篇 | |
中国医学 | 28篇 |
肿瘤学 | 2410篇 |
出版年
2024年 | 50篇 |
2023年 | 383篇 |
2022年 | 547篇 |
2021年 | 1045篇 |
2020年 | 741篇 |
2019年 | 997篇 |
2018年 | 1183篇 |
2017年 | 874篇 |
2016年 | 934篇 |
2015年 | 1030篇 |
2014年 | 1294篇 |
2013年 | 1823篇 |
2012年 | 2582篇 |
2011年 | 2544篇 |
2010年 | 1341篇 |
2009年 | 1200篇 |
2008年 | 1907篇 |
2007年 | 1978篇 |
2006年 | 1750篇 |
2005年 | 1582篇 |
2004年 | 1432篇 |
2003年 | 1306篇 |
2002年 | 1239篇 |
2001年 | 176篇 |
2000年 | 97篇 |
1999年 | 134篇 |
1998年 | 209篇 |
1997年 | 176篇 |
1996年 | 134篇 |
1995年 | 112篇 |
1994年 | 108篇 |
1993年 | 92篇 |
1992年 | 76篇 |
1991年 | 66篇 |
1990年 | 45篇 |
1989年 | 53篇 |
1988年 | 31篇 |
1987年 | 35篇 |
1986年 | 38篇 |
1985年 | 34篇 |
1984年 | 44篇 |
1983年 | 34篇 |
1982年 | 49篇 |
1981年 | 34篇 |
1980年 | 39篇 |
1979年 | 20篇 |
1978年 | 22篇 |
1977年 | 23篇 |
1976年 | 27篇 |
1973年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
Louise Theodosiou 《Child and Adolescent Mental Health》2020,25(1):43-44
In order to support children and young people who are exploring their gender, we need to develop a shared understanding of gender identities and enhance the evidence base relating to long-term outcomes. All professionals working with children and young people should be trained in gender diversity. Health-care systems must be adapted to enable us to record gender identity; outcome measures should be developed that accommodate different gender identities. In doing so, we will develop clearer information about the number of children and young people who are exploring their gender and the way that gender identities develop throughout childhood. We will also start to demystify gender and work to enhance understanding and acceptance of diversity. 相似文献
994.
Rupa Narayan MD Traci M. Blonquist MS Ashkan Emadi MD PhD Robert P. Hasserjian MD Meghan Burke BS Christopher Lescinskas BS Donna S. Neuberg ScD Andrew M. Brunner MD Gabriela Hobbs MD Hanno Hock MD PhD Steven L. McAfee MD Yi-Bin Chen MD Eyal Attar MD Timothy A. Graubert MD Christina Bertoli MSN Jenna A. Moran MSN Meghan K. Bergeron MSN Julia E. Foster MSN Aura Y. Ramos BSN Tina T. Som BSN Megan K. Vartanian BSN RN Jennifer L. Story LPN Kristin McGregor MS Molly Macrae BS Tanya Behnan BS Margaret C. Wey PhD Jessica Rae BSN Frederic I. Preffer PhD Patricia Lesho BA Vu H. Duong MD Mason L. Mann BA Karen K. Ballen MD Christine Connolly BS Philip C. Amrein MD Amir T. Fathi MD 《Cancer》2020,126(6):1264-1273
995.
Doreen A. Ezeife MD Francois Dionne PhD Aline Fusco Fares MD Ellen Laura Rose Cusano MD Rouhi Fazelzad BSc MISt Wenzie Ng BSc MPharm RPh Don Husereau BSc Pharm MSc Farzad Ali BPharm MSc Christina Sit MSc Barry Stein B.Com BCL LLB Jennifer H. Law MSc Lisa Le MSc Peter Michael Ellis MD MMed PhD Scott Berry MD Stuart Peacock PhD Craig Mitton PhD Craig C. Earle MD Kelvin K. W. Chan MD PhD Natasha B. Leighl MD MMSc 《Cancer》2020,126(7):1530-1540
996.
997.
998.
999.
Raquel Blazquez Eva Rietkötter Britta Wenske Darius Wlochowitz Daniela Sparrer Elena Vollmer Gunnar Müller Julia Seegerer Xueni Sun Katja Dettmer Alonso Barrantes-Freer Lena Stange Kirsten Utpatel Annalen Bleckmann Hannes Treiber Hanibal Bohnenberger Christof Lenz Matthias Schulz Christian Reimelt Christina Hackl Marian Grade Deram Büyüktas Laila Siam Marko Balkenhol Christine Stadelmann Dieter Kube Michael P. Krahn Martin A. Proescholdt Markus J. Riemenschneider Matthias Evert Peter J. Oefner Chistoph A. Klein Uwe K. Hanisch Claudia Binder Tobias Pukrop 《International journal of cancer. Journal international du cancer》2020,146(11):3170-3183
1000.
Renée T. Fortner Anika Hüsing Laure Dossus Anne Tjønneland Kim Overvad Christina C. Dahm Patrick Arveux Agnès Fournier Marina Kvaskoff Matthias B. Schulze Manuela Bergmann Antonia Trichopoulou Anna Karakatsani Carlo La Vecchia Giovanna Masala Valeria Pala Amalia Mattiello Rosario Tumino Fulvio Ricceri Carla H. van Gils Evelyn M. Monninkhof Catalina Bonet José Ramón Quirós Maria-Jose Sanchez Daniel-Ángel Rodríguez-Palacios Aurelio B Gurrea Pilar Amiano Naomi E. Allen Ruth C. Travis Marc J. Gunter Vivian Viallon Elisabete Weiderpass Elio Riboli Rudolf Kaaks 《International journal of cancer. Journal international du cancer》2020,147(5):1325-1333
Endometrial cancer (EC) incidence rates vary ~10-fold worldwide, in part due to variation in EC risk factor profiles. Using an EC risk model previously developed in the European EPIC cohort, we evaluated the prevention potential of modified EC risk factor patterns and whether differences in EC incidence between a European population and low-risk countries can be explained by differences in these patterns. Predicted EC incidence rates were estimated over 10 years of follow-up for the cohort before and after modifying risk factor profiles. Risk factors considered were: body mass index (BMI, kg/m2), use of postmenopausal hormone therapy (HT) and oral contraceptives (OC) (potentially modifiable); and, parity, ages at first birth, menarche and menopause (environmentally conditioned, but not readily modifiable). Modeled alterations in BMI (to all ≤23 kg/m2) and HT use (to all non-HT users) profiles resulted in a 30% reduction in predicted EC incidence rates; individually, longer duration of OC use (to all ≥10 years) resulted in a 42.5% reduction. Modeled changes in not readily modifiable exposures (i.e., those not contributing to prevention potential) resulted in ≤24.6% reduction in predicted EC incidence. Women in the lowest decile of a risk score based on the evaluated exposures had risk similar to a low risk countries; however, this was driven by relatively long use of OCs (median = 23 years). Our findings support avoidance of overweight BMI and of HT use as prevention strategies for EC in a European population; OC use must be considered in the context of benefits and risks. 相似文献